PL2753187T5 - Sposób zapobiegania i/lub leczenia insulinooporności - Google Patents

Sposób zapobiegania i/lub leczenia insulinooporności

Info

Publication number
PL2753187T5
PL2753187T5 PL12758652.7T PL12758652T PL2753187T5 PL 2753187 T5 PL2753187 T5 PL 2753187T5 PL 12758652 T PL12758652 T PL 12758652T PL 2753187 T5 PL2753187 T5 PL 2753187T5
Authority
PL
Poland
Prior art keywords
preventing
insulin resistance
treating insulin
treating
resistance
Prior art date
Application number
PL12758652.7T
Other languages
English (en)
Other versions
PL2753187T3 (pl
Inventor
Max NIEUWDORP
Willem Meindert De Vos
Original Assignee
Caelus Pharmaceuticals B.V.
Stichting Amsterdam UMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47756609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2753187(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Caelus Pharmaceuticals B.V., Stichting Amsterdam UMC filed Critical Caelus Pharmaceuticals B.V.
Publication of PL2753187T3 publication Critical patent/PL2753187T3/pl
Publication of PL2753187T5 publication Critical patent/PL2753187T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
PL12758652.7T 2011-08-30 2012-08-30 Sposób zapobiegania i/lub leczenia insulinooporności PL2753187T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161528931P 2011-08-30 2011-08-30
NL2007319 2011-08-30
PCT/NL2012/050592 WO2013032328A1 (en) 2011-08-30 2012-08-30 Method for preventing and/or treating insulin resistance
EP12758652.7A EP2753187B2 (en) 2011-08-30 2012-08-30 Method for preventing and/or treating insulin resistance

Publications (2)

Publication Number Publication Date
PL2753187T3 PL2753187T3 (pl) 2019-05-31
PL2753187T5 true PL2753187T5 (pl) 2026-02-09

Family

ID=47756609

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12758652.7T PL2753187T5 (pl) 2011-08-30 2012-08-30 Sposób zapobiegania i/lub leczenia insulinooporności

Country Status (13)

Country Link
US (2) US9433650B2 (pl)
EP (1) EP2753187B2 (pl)
JP (1) JP6116568B2 (pl)
KR (1) KR101982491B1 (pl)
CN (1) CN104244733B (pl)
AU (1) AU2012302364B2 (pl)
BR (1) BR112014004890A8 (pl)
CA (1) CA2851602C (pl)
DK (1) DK2753187T4 (pl)
PL (1) PL2753187T5 (pl)
RU (1) RU2613322C2 (pl)
SG (1) SG11201401811WA (pl)
WO (1) WO2013032328A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201401811WA (en) 2011-08-30 2014-09-26 Amc Amsterdam Method for preventing and/or treating insulin resistance
IN2014DN07752A (pl) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
CA3212215A1 (en) 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA2899925A1 (en) 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
HK1218560A1 (zh) 2013-02-04 2017-02-24 Seres Therapeutics, Inc. 组成与方法
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
EP3074027B1 (en) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN107405369A (zh) 2015-01-09 2017-11-28 瓦赫宁根大学 包含细菌的组合物及将其用于治疗和/或预防胃肠道疾病、代谢疾病和/或其它疾病的方法
JP2019500035A (ja) * 2015-12-31 2019-01-10 カエルス ファーマシューティカルズ ビー．ヴィ． ユーバクテリウム・ハリー（Ｅｕｂａｃｔｅｒｉｕｍ ｈａｌｌｉｉ）を培養し、保存する方法
CN106974939B (zh) * 2016-01-15 2020-08-25 深圳华大生命科学研究院 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
KR20180120145A (ko) * 2016-02-02 2018-11-05 온코이뮨, 아이앤씨. 렙틴-결핍 병태를 치료하기 위한 cd24 단백질의 용도
RU2730870C2 (ru) * 2016-02-25 2020-08-26 Калус Фармасьютикалс Б.В. Композиции и способы для профилактики и/или лечения недостатка витамина в12
CN109415683B (zh) 2016-04-11 2022-04-15 瓦赫宁恩大学 新细菌物种
MX392555B (es) 2016-09-07 2025-03-24 Univ Temple Composiciones y métodos para el tratamiento de resistencia a la insulina.
AU2018209227B2 (en) * 2017-01-19 2024-10-10 Bactaviva Ab Autologous fecal sample for use in the treatment of microbial dysbiosis
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
JP2021501185A (ja) 2017-10-30 2021-01-14 セレス セラピューティクス インコーポレイテッド 抗生物質耐性を処置するための組成物及び方法
RU2020131222A (ru) * 2018-03-02 2022-04-06 Академис Медис Сентрум Фекальный материал для профилактики или лечения аутоиммунных заболеваний
CA3106315A1 (en) * 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
EP3870691A4 (en) 2018-09-13 2022-09-07 Xbiome Inc. METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL AND INFLAMMATORY DISORDERS
US20220160617A1 (en) 2019-04-09 2022-05-26 Dermbiont, Inc. Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
NL2024569B1 (en) 2019-12-24 2021-09-06 Univ Wageningen Bacterium comprising myo-inositol to propionate pathway
JP2022544369A (ja) 2019-08-14 2022-10-18 ヴァーヘニンゲン・ウニヴェルシテイト ミオ－イノシトール－プロピオネート経路を含む細菌
RU2734336C1 (ru) * 2020-03-27 2020-10-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ ранней неинвазивной диагностики метаболических нарушений у детей и подростков
TW202206062A (zh) 2020-04-24 2022-02-16 美國坦普大學 高等教育聯邦系統 治療非酒精性脂肪肝炎的方法
AU2021360828A1 (en) * 2020-10-14 2023-06-15 Dermbiont, Inc. Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes
CN113604400B (zh) * 2021-08-26 2023-06-02 王玉莹 具有预防或治疗糖尿病作用的新型乳杆菌yuyingw
NL2036594B1 (en) 2023-12-20 2025-07-04 Univ Wageningen Bacterium comprising phytate-degradation pathway

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6227863B1 (en) 1998-02-18 2001-05-08 Donald Spector Phonics training computer system for teaching spelling and reading
US6224863B1 (en) * 1998-10-30 2001-05-01 University Of South Carolina Antibiotic composition from alcaligenes species and method for making and using the same
EP1228769A1 (de) * 2001-02-02 2002-08-07 Jörg-Peter Prof. Schür Symbiontisches Regenerativum
JP4307006B2 (ja) * 2002-03-28 2009-08-05 キリンフードテック株式会社 糖尿病予防剤
AP2005003208A0 (en) † 2002-07-18 2005-03-31 Kemira Phosphates Pty Ltd Megasphaera elsdenii strain and its uses.
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
EP2460872A1 (en) † 2004-12-22 2012-06-06 Michigan Biotechnology Institute Recombinant microorganisms for increased production of organic acids
US20080069861A1 (en) * 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
EP2102350A4 (en) * 2006-12-18 2012-08-08 Univ St Louis DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES
JP5350626B2 (ja) * 2007-12-20 2013-11-27 キリンフードテック株式会社 樹状細胞活性化用組成物
US20110189149A1 (en) † 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
EP2337569A4 (en) * 2008-09-25 2013-04-03 Univ New York COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
ES2666331T3 (es) * 2009-01-23 2018-05-04 Kadant Inc. Sistema para suministrar desempeño de desaguado mejorado en una máquina para fabricar papel
US20120027737A1 (en) † 2009-03-25 2012-02-02 Chr-Hansen A/S Use of probiotics to ameliorate diet-induced insulin resistance
CA2776420A1 (en) † 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
US8586025B2 (en) * 2010-05-18 2013-11-19 Able Corporation Method of inhibiting methanogenesis
WO2012142605A1 (en) 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
SG11201401811WA (en) 2011-08-30 2014-09-26 Amc Amsterdam Method for preventing and/or treating insulin resistance
JP2019500035A (ja) † 2015-12-31 2019-01-10 カエルス ファーマシューティカルズ ビー．ヴィ． ユーバクテリウム・ハリー（Ｅｕｂａｃｔｅｒｉｕｍ ｈａｌｌｉｉ）を培養し、保存する方法

Also Published As

Publication number Publication date
DK2753187T3 (en) 2019-01-28
CA2851602A1 (en) 2013-03-07
JP2014527068A (ja) 2014-10-09
DK2753187T4 (da) 2025-10-20
KR20140128936A (ko) 2014-11-06
KR101982491B1 (ko) 2019-05-27
EP2753187B1 (en) 2018-10-24
AU2012302364B2 (en) 2016-07-28
RU2014112223A (ru) 2015-10-10
BR112014004890A8 (pt) 2018-02-06
AU2012302364A1 (en) 2014-04-17
JP6116568B2 (ja) 2017-04-19
US20160317589A1 (en) 2016-11-03
US20140294774A1 (en) 2014-10-02
CA2851602C (en) 2020-07-14
EP2753187A1 (en) 2014-07-16
CN104244733A (zh) 2014-12-24
US9433650B2 (en) 2016-09-06
BR112014004890A2 (pt) 2017-03-21
EP2753187B2 (en) 2025-08-06
CN104244733B (zh) 2017-07-28
PL2753187T3 (pl) 2019-05-31
SG11201401811WA (en) 2014-09-26
WO2013032328A1 (en) 2013-03-07
RU2613322C2 (ru) 2017-03-15
US9623055B2 (en) 2017-04-18

Similar Documents

Publication Publication Date Title
SG11201401811WA (en) Method for preventing and/or treating insulin resistance
EP2890391A4 (en) METHOD AND COMPOSITION FOR TREATING HYPERGLYCEMIA
EP2804646A4 (en) MULTI-DOSES SYRINGE AND ASSOCIATED METHOD
PL2696754T3 (pl) Urządzenie i sposób pomiaru stresu
EP2615533A4 (en) INTERACTION PROCEDURE AND INTERACTION DEVICE
GB2494420B (en) Rotary control and method
SI2252312T1 (sl) Postopki za preprečevanje ali zdravljenje insulinske rezistence
IL234700A0 (en) A preparation for the prevention and/or treatment of a skin disease and a method for obtaining it
GB201122195D0 (en) Composition and method
PT2663864T (pt) Método de avaliação de imunodiversidade e seu uso
GB201408236D0 (en) Composition and method
EP2755363A4 (en) METHOD AND DEVICE FOR FAST DATA DISTRIBUTION
EP2698762A4 (en) EYEWEAR DETECTION DEVICE, EYE DETECTION METHOD, AND PROGRAM
EP2521550A4 (en) METHOD OF TREATMENT
GB201101862D0 (en) Method and device
SG11201400204VA (en) Fish anesthetic and method
GB201106433D0 (en) Composition and method
EP2914515A4 (en) METHOD AND PLANT FOR A WAREHOUSE
PL2684100T3 (pl) Sposób impregnacji i urządzenie do impregnacji
GB201105523D0 (en) Treatment method
IL238331A0 (en) A method for treating type I and type II diabetes
ZA201502205B (en) Ectoparasitic treatment method and composition
IL229438A0 (en) Methods for treating obesity and/or metabolic syndrome
GB201222820D0 (en) Woolscouring method and composition
GB201120703D0 (en) Heat-treatment method and apparatus